Critical Outcome Technologies preclinical data

In an animal model of breast cancer, 200 mg/kg oral COTI-2 daily for 5 days prior to tumor implantation and 5 days/week thereafter inhibited tumor growth by 78% at day 38 vs. vehicle control (p<0.001)...